Decadron with Xylocaine Interactions
There are 1074 drugs known to interact with Decadron with Xylocaine (dexamethasone / lidocaine), along with 29 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 182 are major, 823 are moderate, and 69 are minor.
- View all 1074 medications that may interact with Decadron with Xylocaine
- View Decadron with Xylocaine alcohol/food interactions (3)
- View Decadron with Xylocaine disease interactions (29)
Most frequently checked interactions
View interaction reports for Decadron with Xylocaine (dexamethasone / lidocaine) and the medicines listed below.
- Aridol (mannitol)
- Brevital Sodium (methohexital)
- butabarbital
- Cerebyx (fosphenytoin)
- Dilantin (phenytoin)
- FUDR (floxuridine)
- GastroMARK (ferumoxsil)
- Geref Diagnostic (sermorelin)
- lorlatinib
- Mesantoin (mephenytoin)
- Methergine (methylergonovine)
- Nembutal (pentobarbital)
- Peganone (ethotoin)
- phenobarbital
- secobarbital
- Thiola (tiopronin)
- Xylocaine-MPF (lidocaine)
- Zokinvy (lonafarnib)
Decadron with Xylocaine alcohol/food interactions
There are 3 alcohol/food interactions with Decadron with Xylocaine (dexamethasone / lidocaine).
Decadron with Xylocaine disease interactions
There are 29 disease interactions with Decadron with Xylocaine (dexamethasone / lidocaine) which include:
- cardiovascular dysfunction
- infections
- prematurity
- hepatic dysfunction
- renal dysfunction
- seizures
- sinus/AV node dysfunction
- electrolyte imbalance
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.